182 related articles for article (PubMed ID: 36340147)
1. Mechanistic Insight into the Binding of Huperzine a with Human Transferrin: Computational, Spectroscopic and Calorimetric Approaches.
Atiya A; Alhumaydhi FA; Shamsi A; Olatunde A; Alsagaby SA; Al Abdulmonem W; Sharaf SE; Shahwan M
ACS Omega; 2022 Nov; 7(43):38361-38370. PubMed ID: 36340147
[TBL] [Abstract][Full Text] [Related]
2. Spectroscopic, calorimetric and in silico insight into the molecular interactions of Memantine with human transferrin: Implications of Alzheimer's drugs.
Shamsi A; Shahwan M; Alhumaydhi FA; Alwashmi ASS; Aljasir MA; Alsagaby SA; Al Abdulmonem W; Hassan MI; Islam A
Int J Biol Macromol; 2021 Nov; 190():660-666. PubMed ID: 34508722
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the Interactions of Fluoxetine with Human Transferrin Employing Spectroscopic, Calorimetric, and
Khan MS; Shahwan M; Shamsi A; Alhumaydhi FA; Alsagaby SA; Al Abdulmonem W; Abdullaev B; Yadav DK
ACS Omega; 2022 Mar; 7(10):9015-9023. PubMed ID: 35309456
[TBL] [Abstract][Full Text] [Related]
4. Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease.
Friedli MJ; Inestrosa NC
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770940
[TBL] [Abstract][Full Text] [Related]
5. Bivalent ligands derived from Huperzine A as acetylcholinesterase inhibitors.
Haviv H; Wong DM; Silman I; Sussman JL
Curr Top Med Chem; 2007; 7(4):375-87. PubMed ID: 17305579
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity.
Wong DM; Greenblatt HM; Dvir H; Carlier PR; Han YF; Pang YP; Silman I; Sussman JL
J Am Chem Soc; 2003 Jan; 125(2):363-73. PubMed ID: 12517147
[TBL] [Abstract][Full Text] [Related]
7. Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A.
Raves ML; Harel M; Pang YP; Silman I; Kozikowski AP; Sussman JL
Nat Struct Biol; 1997 Jan; 4(1):57-63. PubMed ID: 8989325
[TBL] [Abstract][Full Text] [Related]
8. Production and enhancement of the acetylcholinesterase inhibitor, huperzine A, from an endophytic Alternaria brassicae AGF041.
Zaki AG; El-Shatoury EH; Ahmed AS; Al-Hagar OEA
Appl Microbiol Biotechnol; 2019 Jul; 103(14):5867-5878. PubMed ID: 31119352
[TBL] [Abstract][Full Text] [Related]
9. How does huperzine A enter and leave the binding gorge of acetylcholinesterase? Steered molecular dynamics simulations.
Xu Y; Shen J; Luo X; Silman I; Sussman JL; Chen K; Jiang H
J Am Chem Soc; 2003 Sep; 125(37):11340-9. PubMed ID: 16220957
[TBL] [Abstract][Full Text] [Related]
10. Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer's Disease?
Qian ZM; Ke Y
Front Aging Neurosci; 2014; 6():216. PubMed ID: 25191267
[TBL] [Abstract][Full Text] [Related]
11. In vitro production of huperzine A, a promising drug candidate for Alzheimer's disease.
Ma X; Gang DR
Phytochemistry; 2008 Jul; 69(10):2022-8. PubMed ID: 18538805
[TBL] [Abstract][Full Text] [Related]
12. Global transcriptome analysis of Huperzia serrata and identification of critical genes involved in the biosynthesis of huperzine A.
Yang M; You W; Wu S; Fan Z; Xu B; Zhu M; Li X; Xiao Y
BMC Genomics; 2017 Mar; 18(1):245. PubMed ID: 28330463
[TBL] [Abstract][Full Text] [Related]
13. Endophytic Fungal Community of
Cui L; Noushahi HA; Zhang Y; Liu J; Cosoveanu A; Liu Y; Yan L; Zhang J; Shu S
Molecules; 2021 Feb; 26(4):. PubMed ID: 33567664
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Insight into Binding of Huperzine A with Human Serum Albumin: Computational and Spectroscopic Approaches.
Shamsi A; Shahwan M; Khan MS; Alhumaydhi FA; Alsagaby SA; Al Abdulmonem W; Abdullaev B; Yadav DK
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164061
[TBL] [Abstract][Full Text] [Related]
15. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.
Huang XT; Qian ZM; He X; Gong Q; Wu KC; Jiang LR; Lu LN; Zhu ZJ; Zhang HY; Yung WH; Ke Y
Neurobiol Aging; 2014 May; 35(5):1045-54. PubMed ID: 24332448
[TBL] [Abstract][Full Text] [Related]
16. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.
Wang R; Yan H; Tang XC
Acta Pharmacol Sin; 2006 Jan; 27(1):1-26. PubMed ID: 16364207
[TBL] [Abstract][Full Text] [Related]
17. The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease.
Zangara A
Pharmacol Biochem Behav; 2003 Jun; 75(3):675-86. PubMed ID: 12895686
[TBL] [Abstract][Full Text] [Related]
18. Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia.
Zhang HY; Zheng CY; Yan H; Wang ZF; Tang LL; Gao X; Tang XC
Chem Biol Interact; 2008 Sep; 175(1-3):396-402. PubMed ID: 18565502
[TBL] [Abstract][Full Text] [Related]
19. Production of huperzine A and other Lycopodium alkaloids in Huperzia species grown under controlled conditions and in vitro.
Ishiuchi K; Park JJ; Long RM; Gang DR
Phytochemistry; 2013 Jul; 91():208-19. PubMed ID: 23306162
[TBL] [Abstract][Full Text] [Related]
20. A novel endophytic Huperzine A-producing fungus, Shiraia sp. Slf14, isolated from Huperzia serrata.
Zhu D; Wang J; Zeng Q; Zhang Z; Yan R
J Appl Microbiol; 2010 Oct; 109(4):1469-78. PubMed ID: 20602655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
